DionyMed Brands Inc. (CNSX:DYME) announced that it has signed an investment agreement with new investor Alumina Partners (Ontario) Ltd. for gross proceeds of up to CAD 32 million on June 6, 2019. The company will issue units in the transaction. Each unit consists of one subordinate voting share and one half of one subordinate voting share purchase warrant. Each warrant is set at a 50% premium to the market price of the subordinate voting shares on the Canadian Securities Exchange. Should the 10-day volume weight average price of the subordinate voting shares, as traded on the exchange, be equal to or greater than a 100% premium to the warrant exercise price, the company may accelerate the expiry date of the warrants by providing investor with notice of its election to do so. In no event may the subordinate voting shares issuable pursuant to the agreement, when aggregated with the subordinate voting shares already held by investor on the date of purchase, exceed 9.99% of company's outstanding subordinate voting shares. A minimum of five trading days must pass between the closing of one issuance of units under the agreement and the initiation of another, subject by waiver by the investor. The price per share of the subordinate voting shares purchased by investor in each issuance of units under the agreement shall be priced at a discount of 15% to 20% the market price, subject to the maximum aggregate discount cap mandated by the exchange in relation to the then-prevailing price per share. The company expects to close the transaction in multiple tranches with a value of up to CAD 2 million per tranche, over a period of 24 months.